Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IDURSULFASE vs IMDEVIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IDURSULFASE vs IMDEVIMAB: Safety Overview

Metric IDURSULFASE IMDEVIMAB
Total FAERS Reports 3,188 432
Deaths Reported 526 24
Death Rate 16.5% 5.6%
Hospitalizations 1,734 202
Average Patient Age 13.2 yrs 56.2 yrs
% Female Patients 1.1% 52.7%
Manufacturer Takeda Pharmaceuticals America, Inc. N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A